Melanie Paige Hoenig, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephrology | 4 | 2015 | 263 | 1.150 |
Why?
|
| Alkalosis, Respiratory | 1 | 2023 | 19 | 0.930 |
Why?
|
| Students, Medical | 3 | 2023 | 1862 | 0.890 |
Why?
|
| Alkalosis | 2 | 2021 | 54 | 0.890 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2022 | 66 | 0.830 |
Why?
|
| Glomerular Filtration Rate | 7 | 2023 | 2166 | 0.800 |
Why?
|
| Adenoma, Villous | 1 | 2021 | 15 | 0.790 |
Why?
|
| Antifibrinolytic Agents | 1 | 2023 | 254 | 0.760 |
Why?
|
| Acid-Base Equilibrium | 2 | 2018 | 185 | 0.730 |
Why?
|
| Adrenal Insufficiency | 1 | 2022 | 184 | 0.720 |
Why?
|
| Hyponatremia | 1 | 2022 | 298 | 0.670 |
Why?
|
| Curriculum | 6 | 2023 | 3605 | 0.660 |
Why?
|
| Acid-Base Imbalance | 1 | 2018 | 41 | 0.650 |
Why?
|
| Education, Medical | 2 | 2023 | 1722 | 0.620 |
Why?
|
| Hypocalcemia | 1 | 2019 | 191 | 0.610 |
Why?
|
| Microscopy | 1 | 2022 | 902 | 0.570 |
Why?
|
| Hypovolemia | 1 | 2016 | 45 | 0.560 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2023 | 2200 | 0.560 |
Why?
|
| Nephrons | 2 | 2016 | 220 | 0.560 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 4251 | 0.560 |
Why?
|
| Creatinine | 7 | 2023 | 1919 | 0.540 |
Why?
|
| Vocational Guidance | 1 | 2015 | 13 | 0.530 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2016 | 113 | 0.520 |
Why?
|
| Preceptorship | 1 | 2015 | 61 | 0.500 |
Why?
|
| Kidney Pelvis | 1 | 2015 | 188 | 0.480 |
Why?
|
| Sodium | 2 | 2016 | 1622 | 0.460 |
Why?
|
| Ureteral Obstruction | 1 | 2015 | 296 | 0.450 |
Why?
|
| Computer-Assisted Instruction | 1 | 2015 | 365 | 0.400 |
Why?
|
| Potassium | 3 | 2023 | 1336 | 0.400 |
Why?
|
| Teaching | 3 | 2020 | 1174 | 0.390 |
Why?
|
| Teaching Rounds | 1 | 2015 | 253 | 0.390 |
Why?
|
| Urology | 1 | 2015 | 399 | 0.370 |
Why?
|
| Career Choice | 2 | 2015 | 744 | 0.360 |
Why?
|
| Kidney | 6 | 2023 | 7184 | 0.360 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 2542 | 0.330 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2020 | 1008 | 0.330 |
Why?
|
| Kidney Diseases | 3 | 2015 | 2148 | 0.330 |
Why?
|
| Thinking | 2 | 2022 | 318 | 0.330 |
Why?
|
| Internet | 1 | 2015 | 3056 | 0.210 |
Why?
|
| Cystatin C | 1 | 2023 | 250 | 0.210 |
Why?
|
| Urinalysis | 2 | 2022 | 369 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2018 | 2556 | 0.200 |
Why?
|
| Electrolytes | 1 | 2022 | 282 | 0.190 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 3841 | 0.190 |
Why?
|
| Renal Tubular Transport, Inborn Errors | 1 | 2019 | 12 | 0.180 |
Why?
|
| Hypokalemia | 1 | 2021 | 153 | 0.180 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 19 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2019 | 94 | 0.170 |
Why?
|
| Humans | 30 | 2023 | 744366 | 0.160 |
Why?
|
| Albuminuria | 1 | 2022 | 681 | 0.160 |
Why?
|
| Hyperaldosteronism | 1 | 2021 | 240 | 0.150 |
Why?
|
| Laboratories | 1 | 2021 | 463 | 0.150 |
Why?
|
| Living Donors | 1 | 2021 | 621 | 0.150 |
Why?
|
| Amino Acids | 1 | 2023 | 1737 | 0.150 |
Why?
|
| Problem-Based Learning | 1 | 2020 | 361 | 0.150 |
Why?
|
| Juxtaglomerular Apparatus | 1 | 2016 | 15 | 0.140 |
Why?
|
| Renin-Angiotensin System | 2 | 2023 | 758 | 0.140 |
Why?
|
| Body Fluid Compartments | 1 | 2016 | 52 | 0.140 |
Why?
|
| Pressoreceptors | 1 | 2016 | 100 | 0.140 |
Why?
|
| Trust | 1 | 2021 | 505 | 0.140 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1968 | 0.140 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2015 | 22 | 0.130 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2021 | 740 | 0.130 |
Why?
|
| Persuasive Communication | 1 | 2015 | 59 | 0.130 |
Why?
|
| Nephritis, Interstitial | 1 | 2016 | 154 | 0.130 |
Why?
|
| Blood Volume | 1 | 2016 | 565 | 0.130 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2016 | 132 | 0.120 |
Why?
|
| Liver Cirrhosis | 2 | 2023 | 1862 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1516 | 0.120 |
Why?
|
| Renal Dialysis | 2 | 2021 | 1783 | 0.120 |
Why?
|
| Cardiac Output | 1 | 2016 | 854 | 0.120 |
Why?
|
| Neprilysin | 1 | 2016 | 439 | 0.110 |
Why?
|
| Vascular Resistance | 1 | 2016 | 936 | 0.110 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2015 | 416 | 0.110 |
Why?
|
| Diuretics | 1 | 2016 | 591 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2016 | 535 | 0.110 |
Why?
|
| Water-Electrolyte Balance | 1 | 2014 | 346 | 0.110 |
Why?
|
| Fluid Therapy | 1 | 2016 | 593 | 0.100 |
Why?
|
| Kidney Glomerulus | 1 | 2014 | 697 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 581 | 0.100 |
Why?
|
| Phosphates | 1 | 2014 | 785 | 0.090 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 923 | 0.090 |
Why?
|
| Adenoma | 1 | 2021 | 2174 | 0.090 |
Why?
|
| Mentors | 1 | 2015 | 631 | 0.090 |
Why?
|
| Water | 1 | 2014 | 1395 | 0.080 |
Why?
|
| Pharmaceutical Preparations | 1 | 2015 | 1070 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2016 | 1580 | 0.070 |
Why?
|
| Program Development | 1 | 2013 | 1316 | 0.070 |
Why?
|
| Schools, Medical | 1 | 2013 | 881 | 0.070 |
Why?
|
| Learning | 1 | 2015 | 1711 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 2073 | 0.060 |
Why?
|
| Motivation | 1 | 2015 | 1971 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4687 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2019 | 6077 | 0.060 |
Why?
|
| Diet | 1 | 2022 | 7937 | 0.060 |
Why?
|
| Terminal Care | 1 | 2015 | 1694 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 2535 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 3229 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2016 | 4446 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2011 | 1591 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 11726 | 0.040 |
Why?
|
| Albumins | 1 | 2022 | 568 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.040 |
Why?
|
| Renin | 1 | 2021 | 642 | 0.040 |
Why?
|
| Proteins | 1 | 2014 | 6100 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2019 | 437 | 0.040 |
Why?
|
| Physicians | 1 | 2015 | 4567 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1184 | 0.030 |
Why?
|
| Aldosterone | 1 | 2021 | 877 | 0.030 |
Why?
|
| Organic Anion Transporters | 1 | 2015 | 100 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 1401 | 0.030 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.030 |
Why?
|
| Uremia | 1 | 2015 | 200 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Observer Variation | 1 | 2020 | 2593 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 683 | 0.030 |
Why?
|
| Adult | 4 | 2022 | 214052 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2020 | 1210 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 163288 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13693 | 0.030 |
Why?
|
| Female | 6 | 2023 | 380193 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2015 | 41005 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1181 | 0.030 |
Why?
|
| Male | 6 | 2023 | 350115 | 0.020 |
Why?
|
| Biological Transport | 1 | 2015 | 2120 | 0.020 |
Why?
|
| Child | 1 | 2019 | 77709 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2014 | 798 | 0.020 |
Why?
|
| Animals | 3 | 2014 | 168768 | 0.020 |
Why?
|
| Cocaine-Related Disorders | 1 | 2011 | 460 | 0.020 |
Why?
|
| Middle Aged | 5 | 2021 | 213390 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 21696 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2108 | 0.020 |
Why?
|
| HIV Infections | 1 | 2011 | 16715 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 6755 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2014 | 4196 | 0.010 |
Why?
|
| Homeostasis | 1 | 2014 | 3339 | 0.010 |
Why?
|
| Urban Population | 1 | 2011 | 2022 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2011 | 1872 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19905 | 0.010 |
Why?
|
| Viral Load | 1 | 2011 | 3300 | 0.010 |
Why?
|
| Hypertension | 1 | 2021 | 8479 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 13882 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2011 | 9849 | 0.010 |
Why?
|
| Models, Biological | 1 | 2014 | 9584 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 53290 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 4255 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 23404 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 40559 | 0.000 |
Why?
|
| Risk Factors | 1 | 2011 | 72296 | 0.000 |
Why?
|